Randomized Phase II Biomarker Pilot Trial of Fluvastatin Use in Women With Ductal Carcinoma in Situ (DCIS) or Stage I Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 12 Dec 2012
At a glance
- Drugs Fluvastatin (Primary)
- Indications Breast cancer; Early breast cancer
- Focus Biomarker; Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 08 Feb 2010 Status changed from recruiting to completed.
- 01 Jan 2010 Primary endpoint results published in the Breast Cancer Research and Treatment 119: 137-144, No. 1, 1 Jan 2010.